Data on Veterinary Medicine Reported by Pamela D. Jones and Colleagues (Response to tigilanol tiglate in dogs with mast cell tumors).

A recent study conducted in Brisbane, Australia, focused on the response rate of tigilanol tiglate in dogs with mast cell tumors. The research involved 149 dogs with 151 tumors, showing that 75% of dogs achieved a complete response after one dose of tigilanol tiglate, with a durable response in 64% of dogs after one year. The study concluded that tigilanol tiglate is an effective local treatment option for mast cell tumors in dogs, but careful case selection and client education are necessary before electing this treatment. [Extracted from the article]